{
    "root": "47119208-bd76-47ac-9768-b044d893952c",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "IBSRELA",
    "value": "20250122",
    "ingredients": [
        {
            "name": "TENAPANOR HYDROCHLORIDE",
            "code": "50605O2ZNS",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_36807"
        }
    ],
    "indications": {
        "text": "ibsrela indicated treatment irritable bowel syndrome constipation ( ibs-c ) adults .",
        "doid_entities": [
            {
                "text": "irritable bowel syndrome (DOID:9778)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9778"
            },
            {
                "text": "syndrome (DOID:225)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_225"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "recommended ibsrela adults 50 mg orally twice daily .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "ibsrela tablets contain 50 mg tenapanor oval , white off-white , debossed `` 50 `` one side `` 5791 `` side . ibsrela supplied white , opaque , high-density polyethylene bottle containing 60 tablets silica gel canister ( desiccant ) screw-top polypropylene child-resistant cap lined induction-activated aluminum foil liner ( ndc 73154-050-60 ) .",
    "adverseReactions": "ibsrela contraindicated : patients less 6 years age due risk serious dehydration [ ( 5.1 ) , ( 8.4 ) ] . patients known suspected mechanical gastrointestinal obstruction .",
    "indications_original": "IBSRELA is indicated for treatment of irritable bowel syndrome with constipation (IBS-C) in adults.",
    "contraindications_original": "The recommended dosage of IBSRELA in adults is 50 mg orally twice daily.",
    "warningsAndPrecautions_original": "IBSRELA tablets contain 50 mg tenapanor and are oval, white to off-white, debossed with \"50\" on one side and \"5791\" on the other side.\n                  IBSRELA is supplied in a white, opaque, high-density polyethylene bottle containing 60 tablets with a silica gel canister (as the desiccant) and screw-top polypropylene child-resistant cap lined and induction-activated aluminum foil liner (NDC 73154-050-60).",
    "adverseReactions_original": "IBSRELA is contraindicated in:\n                  \n                     Patients less than 6 years of age due to the risk of serious dehydration [see Warnings and Precautions (5.1), Use in Specific Populations (8.4)].\n                     \n                     Patients with known or suspected mechanical gastrointestinal obstruction.",
    "drug": [
        {
            "name": "IBSRELA",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_36807"
        }
    ]
}